Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : InvestRight - Short Term Trading St -- Ignore unavailable to you. Want to Upgrade?

To: RSkarsten who wrote (687)	12/22/1998 9:28:00 PM
From: Jeffrey L. Henken	Respond to of 939

Here is NHLT's problem: Management believes that the Company has sufficient capital resources to fund its anticipated operations until some time in the fourth quarter of 1998. Management estimates that its current level of operations requires approximately $80,000 per month in cash based upon average monthly cash flows during the first nine months of 1998. Although management believes that sales of the POWERX Card will improve appreciably during the next several quarters, unless the Company is able to raise additional revenue from operating activities or from additional sales of corporate debt or equity securities, the Company may encounter a cash flow shortage in the fourth quarter of 1998. To overcome this potential cash flow shortage, management intends to seek additional equity or debt capital through private sources, although there can be no assurance such fund will be available. As of the date hereof, the Company has not entered into any firm agreements or understanding for the raising of capital from private sources. sec.yahoo.com Limited upside unless funding is acquired in the right fashion. Regards, Jeff

To: RSkarsten who wrote (687)	12/22/1998 9:48:00 PM
From: Jeffrey L. Henken	Respond to of 939

LPTI has some problems too but a FDA approval could be a real boon. Keep in mind the following information is publicly filed online with Edgar. On the other hand I have seen stocks descend rather quickly after FDA approval unless they have the proper manufacturing and distribution agreements in place. LPTI will need more money, an ISO 9001 manufacturer and more. They may have it all together already but I would like someone to walk me through that who has all the answers. Here is the real pluses and minuses on this one that I found here online: The Company anticipates growth from additional license agreements, management fees, and sales and rentals of equipment during 1998. New license agreements and Wound Healing Center contracts will essentially mirror the agreements the Company now has in place. The Company intends to continue its practice of acting as a management consultant to healthcare providers, for a fixed monthly fee. In addition, the Company continues to explore the possibility of public or private placements of its common stock, but cannot provide any assurance that any such financing can be obtained. The Company learned that Medicare Region D is challenging payments made to the Company's closed subsidiary, Longport Medical, Inc. during 1995 and 1994. All amounts paid are being challenged and Management does not yet know whether any amounts will need to be repaid to Medicare. As of September 30, 1998, no hearing date has been scheduled. sec.yahoo.com Regards, Jeff